{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-178792","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2022-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.493454+00:00","generated_at":"2026-06-25T00:04:10.618884+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Tarsus shareholders elect 4 Class II directors, ratify E&Y as auditor at annual meeting","bullets":["Votes for nominees: Ackermann 10.09M, Azamian 10.22M, Crane 11.04M, Yeu-Lin 10.91M; ~4.27M broker non-votes each.","Ratification of Ernst & Young as auditor approved with 15.32M votes for, 1,027 against, 37 abstain.","Four incumbent directors continue: Link, Chaudhuri, Goldberg, Yarno."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-178792","json":"https://secwatch.observer/filing/0001193125-22-178792.json","markdown":"https://secwatch.observer/filing/0001193125-22-178792.md","text":"https://secwatch.observer/filing/0001193125-22-178792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000119312522178792/0001193125-22-178792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000119312522178792/d301085d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:04:10.618884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}